UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Small Immunomodulatory Molecules as Potential Therapeutics in Experimental Murine Models of Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS)

International journal of molecular sciences, 2021-03, Vol.22 (5), p.2573

2021

Volltextzugriff (PDF)

Ocular Pharmacokinetics of Moxifloxacin After Topical Treatment of Animals and Humans

Survey of ophthalmology, 2005-11, Vol.50 (6), p.S32-S45

2005

Volltextzugriff (PDF)

Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: a safety and preliminary efficacy trial

Eye (London), 2021-12, Vol.35 (12), p.3292-3301

2021

Volltextzugriff (PDF)

Efficacy and Safety of a Fixed Combination of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Once Daily for Open-Angle Glaucoma or Ocular Hypertension

American journal of ophthalmology, 2005-08, Vol.140 (2), p.242.e1-242.e11

2005

Volltextzugriff (PDF)

A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues

Journal of ocular pharmacology and therapeutics, 2007-08, Vol.23 (4), p.335

2007

Volltextzugriff (PDF)

Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy

Retina (Philadelphia, Pa.), 2003-02, Vol.23 (1), p.14-23

2003

Volltextzugriff (PDF)

Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis

Advances in therapy, 2007-11, Vol.24 (6), p.1221-1232

2007

Volltextzugriff (PDF)

Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis

Allergy and asthma proceedings, 2007-07, Vol.28 (4), p.427

2007

Volltextzugriff (PDF)

Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study

Clinical therapeutics, 2004-08, Vol.26 (8), p.1237-1248

2004

Volltextzugriff (PDF)

Safety and tolerability of olopatadine 0.2% in children and adolescents

Journal of ocular pharmacology and therapeutics, 2007-08, Vol.23 (4), p.366

2007

Volltextzugriff (PDF)

Quick and Effective Disinfection of Hospital Rooms after Discharge of Patients

American journal of infection control, 2018-06, Vol.46 (6), p.S29-S30

2018

Volltextzugriff (PDF)

ADS-55 - Quick and Effective Disinfection of Hospital Rooms after Discharge of Patients

American journal of infection control, 2018-06, Vol.46 (6), p.S29-S30

2018

Volltextzugriff (PDF)

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis

Current medical research and opinion, 2005-05, Vol.21 (5), p.683-691

2005

Volltextzugriff (PDF)

Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration

Allergy and asthma proceedings, 2004-01, Vol.25 (1), p.69

2004

Volltextzugriff (PDF)

Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension

Advances in therapy, 2003-05, Vol.20 (3), p.149-163

2003

Volltextzugriff (PDF)

Anecortave Acetate (15 Milligrams) versus Photodynamic Therapy for Treatment of Subfoveal Neovascularization in Age-Related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2006, Vol.113 (1), p.3-13

2006

Volltextzugriff (PDF)

Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans: The potency, ocular penetration, and safety of moxifloxacin (as VIGAMOX® solution), a topical ophthalmic fourth-generation fluoroquinolone

Survey of ophthalmology, 2005, Vol.50, p.S32-S45

2005

Volltextzugriff (PDF)

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis Some material contained within this manuscript was presented at the American College of Allergy, Asthma and Immunology's Annual Scientific Meeting in Boston, MA, 12–17 November 2004

Current medical research and opinion, 2005-05, Vol.21 (5), p.683-691

2005

Volltextzugriff (PDF)

Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice

Current eye research, 1989, Vol.8 (5), p.499-506

1989

Volltextzugriff (PDF)

IMMUNOPROTECTION OF RATS AGAINST HAEMOPHILUS INFLUENZAE TYPE B DISEASE MEDIATED BY MONOCLONAL ANTIBODY AGAINST A HAEMOPHILUS OUTER-MEMBRANE PROTEIN

The Lancet (British edition), 1982-02, Vol.319 (8268), p.366-368

1982

Volltextzugriff (PDF)

Anecortave Acetate: A Novel Ocular Angiostatic Agent

Ocular Angiogenesis, p.341-354

Volltextzugriff (PDF)

Monoclonal antibodies directed against a cell surface-exposed outer membrane protein of Haemophilus influenzae type b

Infection and Immunity, 1982-04, Vol.36 (1), p.80-88

1982

Volltextzugriff (PDF)

The secretory immunoglobulin A response in the gut [proceedings]

Biochemical Society transactions, 1977, Vol.5 (5), p.1565

1977

Volltextzugriff (PDF)

Cellular parameters of the IgA response

Advances in experimental medicine and biology, 1978, Vol.107, p.19

1978

Volltextzugriff (PDF)

The secretory IgA System of the Gut

Ciba Foundation Symposium 46 ‐ Immunology of the Gut, 1976, p.5-28

1976

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(75)
Buchkapitel
(2)

Sprache

Englisch
(77)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Small Immunomodulatory Molecules as Potential Therapeutics in Experimental Murine Models of Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS)

Ocular Pharmacokinetics of Moxifloxacin After Topical Treatment of Animals and Humans

Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: a safety and preliminary efficacy trial

Efficacy and Safety of a Fixed Combination of Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution Once Daily for Open-Angle Glaucoma or Ocular Hypertension

A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues

Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy

Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis

Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis

Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study

Safety and tolerability of olopatadine 0.2% in children and adolescents

Quick and Effective Disinfection of Hospital Rooms after Discharge of Patients

ADS-55 - Quick and Effective Disinfection of Hospital Rooms after Discharge of Patients

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis

Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration

Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension

Anecortave Acetate (15 Milligrams) versus Photodynamic Therapy for Treatment of Subfoveal Neovascularization in Age-Related Macular Degeneration

Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans: The potency, ocular penetration, and safety of moxifloxacin (as VIGAMOX® solution), a topical ophthalmic fourth-generation fluoroquinolone

Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice

IMMUNOPROTECTION OF RATS AGAINST HAEMOPHILUS INFLUENZAE TYPE B DISEASE MEDIATED BY MONOCLONAL ANTIBODY AGAINST A HAEMOPHILUS OUTER-MEMBRANE PROTEIN

Anecortave Acetate: A Novel Ocular Angiostatic Agent

Monoclonal antibodies directed against a cell surface-exposed outer membrane protein of Haemophilus influenzae type b

The secretory immunoglobulin A response in the gut [proceedings]

Cellular parameters of the IgA response

The secretory IgA System of the Gut

Suchergebnisse filtern